MY ACCOUNT | NEWSLETTER |

Veterinary artificial insemination market to exceed $7B


The worldwide market for artificial insemination in the veterinary sector is forecast to attain a value of $7.4 billion by the end of 2030, according to a report by Grand View Research, Inc. The valuation follows a 2021 market estimate of $4.2 billion. Growth during the forecast period of 2022 to 2030 was expected to reach a CAGR of 6/5%.

The market’s uptick is predicted based on increased rates of demand for animal protein, increased need for productivity among livestock, and increased use of sexed semen. The Food and Agriculture Organization pointed to livestock as 40% of the value of the industry in developed countries worldwide in 2019. In developing countries, livestock accounted for 20% of the market, according to the report. Artificial insemination is expected to help in meeting the demand for beef and dairy.

When viewing the market by segments, cattle took the largest share in 2021 based on high usage of dairy and beef. Moving forward, the segment for swine was expected to grow at the fastest rate. In 2021 by geography, North America held the largest part of the market while Asia Pacific was expected to overtake the share in the coming years of the report.

By type of semen, sexed is expected to grow at the fastest rate, replacing the normal semen segment that previously held the top spot based on accessibility and low cost. By user, the animal husbandry segment was forecast to retain its top spot for revenue as in 2021 due to the fact that most procedures are undertaken on individual farms.


Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Zoetis is Redefining the Feline Veterinary Experience with the Commercial Launch of Bonqat® (pregabalin oral solution) in the U.S.

Like0
Dislike0

Spatio-temporal patterns of tick-borne disease diagnoses in Indiana, USA (2009–2018)

Like0
Dislike0

Abdominal ultrasonographic findings of cats with feline infectious peritonitis: an update

Like0
Dislike0

Pseudohyperkalemia in horses with rhabdomyolysis reported by an enzymatic chemistry analyzer

Like0
Dislike0

Retrospective evaluation of prognosis and survival with various immunosuppressants in 82 dogs diagnosed with meningoencephalitis of unknown etiology (2010-2021).

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2024 - All Rights Reserved
ISSN 2768-198X

Top